• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRECISE-DAPT评分在老年心肌梗死患者中的适用性。

Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction.

作者信息

Guerrero Carme, Ariza-Solé Albert, Formiga Francesc, Martínez-Sellés Manuel, Vidán María T, Aboal Jaime

机构信息

Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona.

Geriatrics Medicine Unit, Internal Medicine Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona.

出版信息

J Geriatr Cardiol. 2018 Dec;15(12):713-717. doi: 10.11909/j.issn.1671-5411.2018.12.003.

DOI:10.11909/j.issn.1671-5411.2018.12.003
PMID:30675142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6330266/
Abstract

BACKGROUND

Elderly patients with acute coronary syndromes (ACS) are at higher risk both for ischemic and bleeding complications. Current guidelines recommend the PRECISE-DAPT score for bleeding risk stratification in this setting, but no study assessed its applicability in elderly patients. This study aimed to assess the performance of the PRECISE-DAPT score in a series of non-selected elderly patients with ACS from routine clinical practice.

METHODS

The IFFANIAM registry included prospectively patients aged ≥ 75 years with ST segment elevation myocardial infarction (STEMI). Main outcome measured was the incidence of relevant bleeding after discharge (bleeding leading to hospital readmission, need for transfusion, intervention, stop of antithrombotic drugs or death). Bleeding risk was classified: (A) according to PRECISE-DAPT values above or not the recommended cut-off point (≥ 25); and (B) according to the quartiles of PRECISE-DAPT values observed in the IFFANIAM series (Q1: < 30; Q2: 30-35; Q3: 36-44; Q4: ≥ 45).

RESULTS

A total of 208 patients were included. Mean age was 81.9 ± 4.5 years. Most patients (92.6%) had a PRECISE-DAPT value > 25. A total of 25 patients (12.0%) had bleeding events and 49 patients (23.6%) died. No significant differences regarding the incidence of bleeding were observed according to the recommended cutt of point ≥ 25. However, a progressive increase in the incidence of bleeding was observed across PRECISE-DAPT quartiles observed in this series ( = 0.038).

CONCLUSIONS

The vast majority of elderly patients have PRECISE-DAPT values above the recommended cut-off point for bleeding risk. Using different cut-off points could be a more rational approach for predicting bleeding risk in these complex patients.

摘要

背景

老年急性冠状动脉综合征(ACS)患者发生缺血性和出血性并发症的风险更高。当前指南推荐使用PRECISE-DAPT评分对该情况下的出血风险进行分层,但尚无研究评估其在老年患者中的适用性。本研究旨在评估PRECISE-DAPT评分在一系列来自常规临床实践的未选择的老年ACS患者中的表现。

方法

IFFANIAM注册研究前瞻性纳入了年龄≥75岁的ST段抬高型心肌梗死(STEMI)患者。主要观察指标为出院后相关出血的发生率(导致再次入院、输血、干预、停用抗血栓药物或死亡的出血)。出血风险分类如下:(A)根据PRECISE-DAPT值是否高于推荐的切点(≥25);(B)根据IFFANIAM研究系列中观察到的PRECISE-DAPT值的四分位数(Q1:<30;Q2:30-35;Q3:36-44;Q4:≥45)。

结果

共纳入208例患者。平均年龄为81.9±4.5岁。大多数患者(92.6%)的PRECISE-DAPT值>25。共有25例患者(12.0%)发生出血事件,49例患者(23.6%)死亡。根据推荐的切点≥25,未观察到出血发生率的显著差异。然而,在本系列中观察到的PRECISE-DAPT四分位数范围内,出血发生率呈逐渐上升趋势(P=0.038)。

结论

绝大多数老年患者的PRECISE-DAPT值高于推荐的出血风险切点。对于这些复杂患者,使用不同的切点可能是预测出血风险更合理的方法。

相似文献

1
Applicability of the PRECISE-DAPT score in elderly patients with myocardial infarction.PRECISE-DAPT评分在老年心肌梗死患者中的适用性。
J Geriatr Cardiol. 2018 Dec;15(12):713-717. doi: 10.11909/j.issn.1671-5411.2018.12.003.
2
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.PRECISE-DAPT 评分预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出血事件的临床价值:来自 SMART-DATE 随机试验的分析。
Circ Cardiovasc Interv. 2020 May;13(5):e008530. doi: 10.1161/CIRCINTERVENTIONS.119.008530. Epub 2020 May 1.
3
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study.4 项 PRECISE-DAPT 评分验证:SWEDEHEART 研究。
J Am Heart Assoc. 2021 Oct 19;10(20):e020974. doi: 10.1161/JAHA.121.020974. Epub 2021 Oct 6.
4
Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.急性冠脉综合征未行血运重建治疗后双联抗血小板治疗的长期出血风险预测
Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e006582. doi: 10.1161/CIRCOUTCOMES.120.006582. Epub 2020 Aug 31.
5
Incidence and Risk Factors for Antiplatelet Therapy-Related Bleeding Complications Among Elderly Patients After Coronary Stenting: A Multicenter Retrospective Observation.老年患者冠状动脉支架置入术后抗血小板治疗相关出血并发症的发生率及危险因素:一项多中心回顾性观察研究
Front Pharmacol. 2021 Jul 30;12:661619. doi: 10.3389/fphar.2021.661619. eCollection 2021.
6
The Predictive Value of PRECISE-DAPT Score for In-Hospital Mortality in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.PRECISE-DAPT评分对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者院内死亡率的预测价值
Angiology. 2019 May;70(5):440-447. doi: 10.1177/0003319718807057. Epub 2018 Oct 15.
7
The Association of a PRECISE-DAPT Score With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction.PRECISE-DAPT 评分与 ST 段抬高型心肌梗死患者无复流的关系。
Angiology. 2022 Jan;73(1):68-72. doi: 10.1177/00033197211010602. Epub 2021 Apr 21.
8
The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.ST段抬高型心肌梗死患者接受直接经皮冠状动脉介入治疗时,PRECISE-DAPT评分与对比剂肾病发生的相关性。
Cardiovasc Interv Ther. 2019 Jul;34(3):207-215. doi: 10.1007/s12928-018-0545-6. Epub 2018 Sep 6.
9
One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.ST 段抬高型心肌梗死患者经院前双联抗血小板治疗后 1 年的生存率。
Circ Cardiovasc Interv. 2018 Sep;11(9):e007241. doi: 10.1161/CIRCINTERVENTIONS.118.007241.
10
Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.老年急性冠脉综合征患者有创治疗后出血风险预测:PRECISE-DAPT 和 PARIS 评分的外部验证。
Int J Cardiol. 2021 Apr 1;328:22-28. doi: 10.1016/j.ijcard.2020.11.065. Epub 2020 Dec 3.

引用本文的文献

1
Bleeding Risk in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Comprehensive Review.老年患者经皮冠状动脉介入治疗的出血风险:一项综合综述。
J Clin Med. 2025 Feb 12;14(4):1194. doi: 10.3390/jcm14041194.
2
Non-ST Elevation Myocardial Infarction in the Elderly. Antithrombotic Therapy and Beyond.老年非ST段抬高型心肌梗死。抗栓治疗及其他。
Rev Cardiovasc Med. 2023 Jul 13;24(7):201. doi: 10.31083/j.rcm2407201. eCollection 2023 Jul.
3
Antiplatelet Therapy for Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

本文引用的文献

1
Differential Prognostic Impact on Mortality of Myocardial Infarction Compared With Bleeding Severity in Contemporary Acute Coronary Syndrome Patients.当代急性冠状动脉综合征患者中,心肌梗死与出血严重程度对死亡率的预后影响差异
Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):829-836. doi: 10.1016/j.rec.2018.02.008. Epub 2018 Apr 12.
2
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.老年急性冠状动脉综合征患者出院后出血的预测:来自 BleeMACS 登记研究的启示。
Thromb Haemost. 2018 May;118(5):929-938. doi: 10.1055/s-0038-1635259. Epub 2018 Apr 3.
3
老年急性冠状动脉综合征患者行经皮冠状动脉介入治疗时的抗血小板治疗
J Clin Med. 2024 Jul 19;13(14):4229. doi: 10.3390/jcm13144229.
4
The Impact of Geriatric Conditions in Elderly Patients with Coronary Heart Disease: A State-of-the-Art Review.老年合并症对老年冠心病患者的影响:最新综述
J Clin Med. 2024 Mar 25;13(7):1891. doi: 10.3390/jcm13071891.
5
Predictive validation of existing bleeding and thromboembolic scores in elderly patients with comorbid atrial fibrillation and acute coronary syndrome.老年合并心房颤动和急性冠状动脉综合征患者现有出血和血栓栓塞评分的预测性验证
J Geriatr Cardiol. 2023 May 28;20(5):330-340. doi: 10.26599/1671-5411.2023.05.001.
6
Prediction of Bleeding by the PRECISE-DAPT Score in Patients with Carotid Artery Stenting.颈动脉支架置入术患者 PRECISE-DAPT 评分预测出血风险。
Cardiovasc Intervent Radiol. 2023 May;46(5):574-578. doi: 10.1007/s00270-023-03419-9. Epub 2023 Apr 3.
7
Epidemiology, Pathophysiology, and Management of Coronary Artery Disease in the Elderly.老年人冠状动脉疾病的流行病学、病理生理学及管理
Int J Angiol. 2022 Aug 25;31(4):244-250. doi: 10.1055/s-0042-1751234. eCollection 2022 Dec.
8
Cardiovascular prevention in elderly patients.老年患者的心血管疾病预防
J Geriatr Cardiol. 2022 May 28;19(5):377-392. doi: 10.11909/j.issn.1671-5411.2022.05.004.
9
Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes.老年急性冠脉综合征患者的抗栓治疗
J Clin Med. 2022 May 26;11(11):3008. doi: 10.3390/jcm11113008.
10
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study.4 项 PRECISE-DAPT 评分验证:SWEDEHEART 研究。
J Am Heart Assoc. 2021 Oct 19;10(20):e020974. doi: 10.1161/JAHA.121.020974. Epub 2021 Oct 6.
Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry.
全球老年综合评估与老年急性冠状动脉综合征患者住院期间出血风险:来自 LONGEVO-SCA 登记研究的启示。
Thromb Haemost. 2018 Mar;118(3):581-590. doi: 10.1055/s-0038-1623532. Epub 2018 Feb 1.
4
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).2017年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的冠状动脉疾病双联抗血小板治疗重点更新:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)冠状动脉疾病双联抗血小板治疗特别工作组。
Eur Heart J. 2018 Jan 14;39(3):213-260. doi: 10.1093/eurheartj/ehx419.
5
Safety and Efficacy of Prasugrel and Ticagrelor in Acute Coronary Syndrome. Results of a "Real World" Multicenter Registry.普拉格雷和替格瑞洛在急性冠状动脉综合征中的安全性和有效性。一项“真实世界”多中心注册研究的结果。
Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):952-959. doi: 10.1016/j.rec.2017.05.003. Epub 2017 May 30.
6
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.经支架植入和随后双联抗血小板治疗(PRECISE-DAPT)的患者预测出血并发症的预测评分的推导和验证:来自临床试验的个体患者数据集的汇总分析。
Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.
7
Frailty predicts major bleeding within 30days in elderly patients with Acute Coronary Syndrome.衰弱可预测老年急性冠状动脉综合征患者30天内的大出血。
Int J Cardiol. 2016 Nov 1;222:590-593. doi: 10.1016/j.ijcard.2016.07.268. Epub 2016 Aug 1.
8
Non-ST-elevation acute coronary syndromes in octogenarians: applicability of the GRACE and CRUSADE scores.老年非ST段抬高型急性冠脉综合征:GRACE和CRUSADE评分的适用性
Rev Port Cardiol. 2014 Oct;33(10):617-27. doi: 10.1016/j.repc.2014.01.025. Epub 2014 Oct 12.
9
Efficacy of bleeding risk scores in elderly patients with acute coronary syndromes.
Rev Esp Cardiol (Engl Ed). 2014 Jun;67(6):463-70. doi: 10.1016/j.rec.2013.10.008. Epub 2014 Feb 21.
10
Epidemiology of acute coronary syndromes in Spain: estimation of the number of cases and trends from 2005 to 2049.西班牙急性冠状动脉综合征的流行病学:2005年至2049年病例数估计及趋势分析
Rev Esp Cardiol (Engl Ed). 2013 Jun;66(6):472-81. doi: 10.1016/j.rec.2013.01.018. Epub 2013 May 8.